Chang‐Yan Li
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Molecular Biology top 10%
- Genomics, phytochemicals, and oxidative stress
- Inflammasome and immune disorders
- RNA modifications and cancer
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
Papers in
-
- Ubiquitin and proteasome pathways 6
- Inflammasome and immune disorders 6
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- Genomics, phytochemicals, and oxidative stress 4
- Immunology 11
- Co-authors
- Yi‐Qun Zhan (50 shared papers)Chang‐Hui Ge (41 shared papers)Miao Yu (45 shared papers)Xiaoming Yang (46 shared papers)Wang‐Xiang Xu (18 shared papers)Rong‐Hua Yin (28 shared papers)Liujun Tang (9 shared papers)Fang Liu (2 shared papers)
- Journals
- Cellular Signalling (4 papers)PLoS ONE (3 papers)FEBS Journal (3 papers)Journal of Cellular Biochemistry (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Chang‐Yan Li
78 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 103
- Hepatology 97
- Molecular Biology 841
- Cancer Research 159
- Immunology 191
- Nephrology 46
Countries citing papers authored by Chang‐Yan Li
This map shows the geographic impact of Chang‐Yan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Yan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Yan Li more than expected).
Fields of papers citing papers by Chang‐Yan Li
This network shows the impact of papers produced by Chang‐Yan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Yan Li. The network helps show where Chang‐Yan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang‐Yan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 275 | |
| 2 | 2019 | 127 | |
| 3 | 2010 | 72 | |
| 4 | 2009 | 55 | |
| 5 | 2020 | 49 | |
| 6 | 2014 | 49 | |
| 7 | 2012 | 47 | |
| 8 | 2009 | 44 | |
| 9 | 2014 | 43 | |
| 10 | 2014 | 42 | |
| 11 | 2018 | 40 | |
| 12 | 2022 | 32 | |
| 13 | 2011 | 31 | |
| 14 | 2012 | 30 | |
| 15 | 2018 | 28 | |
| 16 | 2014 | 28 | |
| 17 | 2017 | 27 | |
| 18 | 2003 | 27 | |
| 19 | 2021 | 24 | |
| 20 | 2019 | 21 |
About Chang‐Yan Li
Chang‐Yan Li is a scholar working on Molecular Biology, Immunology, Hepatology, Surgery and Hematology, having authored 83 papers that have together received 1.5k indexed citations. Recurring topics across this work include Liver physiology and pathology (8 papers), Ubiquitin and proteasome pathways (6 papers), Pancreatic function and diabetes (6 papers), Inflammasome and immune disorders (6 papers), Erythrocyte Function and Pathophysiology (5 papers), RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). The work is most often cited by research in Hepatology (97 citations), Molecular Biology (841 citations), Cancer Research (159 citations), Immunology (191 citations) and Nephrology (46 citations). Chang‐Yan Li has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Yi‐Qun Zhan, Chang‐Hui Ge, Miao Yu, Xiaoming Yang, Wang‐Xiang Xu, Rong‐Hua Yin, Liujun Tang, Fang Liu, Jianhong Zhang and Wei Li. Their work appears in journals such as Cellular Signalling, PLoS ONE, FEBS Journal, Journal of Cellular Biochemistry and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.